Genetic variants and down-regulation of CACNA1H in pheochromocytoma.
Fredrika SvahnKarolina Solhusløkk HöseStenman AdamYaxuan LiuJan CalissendorffEmma ThamÁkos VégváriRoman A ZubarevNa WangReju KorahTobias CarlingJan ZedeniusRobert BränströmCarl Christofer JuhlinCatharina LarssonPublished in: Endocrine-related cancer (2024)
Pheochromocytoma (PCC) and abdominal paraganglioma (aPGL) (together abbreviated PPGL) frequently present with an underlying genetic event in a PPGL driver gene, and additional susceptibility genes are anticipated. Here, we re-analyzed whole-exome sequencing data for PCC patients and identified two patients with rare missense variants in the calcium voltage-gated channel subunit 1H gene (CACNA1H). CACNA1H variants were also found in the clinical setting in PCC patients using targeted sequencing and from analysis of The Cancer Genome Atlas database. In total, CACNA1H variants were found in six PCC cases. Three of these were constitutional, and two are known to have functional consequences on hormone production and gene expression in primary aldosteronism and aldosterone-producing adrenocortical adenoma. In general, PPGL exhibited reduced CACNA1H mRNA expression as compared to normal adrenal. Immunohistochemistry showed strong CACNA1H (CaV3.2) staining in adrenal medulla while PPGL typically had weak or negative staining. Reduced CACNA1H gene expression was especially pronounced in PCC compared to aPGL and in PPGL with cluster 2 kinase signaling phenotype. Furthermore, CACNA1H levels correlated with HIF1A and HIF2A. Moreover, TCGA data revealed a correlation between CACNA1H methylation density and gene expression. Expression of rCacna1h in PC12 cells induced differential protein expression profiles, determined by mass spectrometry, as well as a shift in the membrane potential where maximum calcium currents were observed, as determined by electrophysiology. The findings suggest the involvement of CACNA1H/CaV3.2 in pheochromocytoma development and establish a potential link between the etiology of adrenomedullary and adrenocortical tumor development.
Keyphrases
- gene expression
- genome wide
- copy number
- dna methylation
- end stage renal disease
- mass spectrometry
- newly diagnosed
- ejection fraction
- chronic kidney disease
- single cell
- prognostic factors
- peritoneal dialysis
- poor prognosis
- patient reported outcomes
- squamous cell carcinoma
- machine learning
- high resolution
- endothelial cells
- big data
- oxidative stress
- drug delivery
- risk assessment
- angiotensin ii
- long non coding rna
- high performance liquid chromatography
- high glucose
- diabetic rats
- protein kinase
- simultaneous determination